Suk-tak Chan1, Karleyton C. Evans2, Tian-yue Song1, Andre van der Kouwe1, Bruce R. Rosen1, Yong-ping Zheng3, and Kenneth K. Kwong1
1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States, 2Biogen, Inc., Cambridge, MA, United States, 3Department of Biomedical Engineering, Hong Kong Polytechnic University, Kowloon, Hong Kong
Synopsis
Regional
cerebraovascular reactivity (CVR) to endogenous carbon dioxide (CO2)
during spontaneous breathing (i.e. end-tidal partial pressure of CO2
(PETCO2) measured at rest), was substantially different
from that obtained under externally applied CO2 challenge. Individual
maps of CVR to endogenous CO2 showed significant inter-subject
variability while CVR maps under hypercapnic challenge did not. Such inter-subject variability was not reduced
by correction of respiratory effects. In
addition, the CVR to end-tidal partial pressure of oxygen (PETO2)
during spontaneous breathing shows less inter-subject variability. Our findings question the compatibility of using
CVR during spontaneous breathing as a surrogate of CVR under hypercapnic
challenge.
Introduction
Externally administered
carbon dioxide (CO2) has been commonly used as a vasoactive stimulus
together with the cerebrovascular responses measured with BOLD signal changes
using functional magnetic resonance imaging (fMRI) to assess the regional
cerebrovascular reactivity (CVR) (1).
However, such assessment procedures require a complicated set-up of gas
administration facilities and proper breathing circuit. Recently, the cerebrovascular responses to endogenous
CO2 which is defined as the end-tidal partial pressure of CO2
(PETCO2) measured during spontaneous breathing, has been
proposed to be a surrogate of CVR assessment under hypercapnic challenge (2,3).
Here, we investigated whether the
cerebrovascular responses to endogenous CO2 are compatible with
those under the effect of externally administered CO2. The responses to endogenous O2
during spontaneous breathing were also measured for comparison.Subjects and Methods
Participants: Eleven healthy
volunteers
aged 22- 48 years
who were screened
to exclude neurological disorders were included.
Each of the subjects participated in the fMRI scans during spontaneous
breathing and under external
CO2 challenge. All MRI scanning was performed at the Athinoula A. Martinos Center
for Biomedical Imaging at the Massachusetts General Hospital. The signed informed
consent was obtained prior to participation in the study. All procedures were approved by the
Institutional Review Board at MGH.
Methods: MRI was performed on a 3-Tesla
(Siemens Medical, Erlangen, Germany). Whole brain BOLD-fMRI datasets were
acquired on each volunteer for 10 minutes (TR=1450ms, TE=30ms) when the subjects
were 1) breathing spontaneously, and 2) under external CO2 challenge.
During external CO2 challenge, subjects wore nose-clip and breathed
through a mouth-piece on a MRI-compatible circuit designed to maintain the PETCO2
within ± 1-2 mmHg of target PETCO2. The external CO2
challenge paradigm consisted of 2 consecutive phases (normocapnia and mild
hypercapnia) repeating 6 times with 3 epochs of 4 mmHg increase and 3 epochs of
8 mmHg increase of PETCO2 above the subject’s resting PETCO2. The normocapnia phase lasted 60-90 seconds,
while the mild hypercapnia phase lasted 30 seconds. Physiological changes including respiration, plethysmography
and the partial pressure of O2 (PO2) and CO2 (PCO2)
were measured by respiratory bellow, pulse oximeter and calibrated gas analyzers
simultaneously with MRI acquisition.
Data analysis: BOLD-fMRI data
were imported into the software AFNI (4).
The pre-processing of BOLD-fMRI data included time-shift
correction,
motion correction, normalization and detrending. Technical delay of PCO2
and PO2 was corrected. Time
series of PETCO2 and PETO2 were
derived at end expiration. CVR values
were derived by regressing BOLD signal changes (∆BOLD) on PETCO2
for the data acquired under external CO2 challenge and during
spontaneous breathing. Regression of ∆BOLD on PETO2 during spontaneous breathing was
also included. Regression coefficient beta (β) value was defined as ∆BOLD per unit change of the regressor (PETCO2). Individual subject
brain volumes with b magnitudes were
registered onto their own anatomical scans and transformed to the standardized
space of Talairach and Tournoux (5).
Monte Carlo simulation was used to correct for multiple comparisons (6).
The BOLD-fMRI data acquired
during spontaneous breathing were analyzed again using the same procedures
above by incorporating RETROICOR (7) before pre-processing to remove the respiratory and cardiac phases.Results
Under external CO2
challenge, most of the brain regions showed increased CVR throughout the gray
and white matter symmetrically on both sides of the brain (Fig 1). For the same group of subjects during
spontaneous breathing, we found that regional CVR in response to PETCO2
obtained from spontaneous breathing was substantially different from CVR in
response to external CO2 challenge. The difference, demonstrated in
individual CVR maps, was manifested in the
significant inter-subject variability. CVR obtained from external CO2
challenge did not show any significant inter-subject
variability. Such inter-subject
variability was not reduced by individual correction of physiological motion
effects using RETROICOR (7). Additionally, we found that for most individuals, CVR maps in response to
PETO2 during spontaneous breathing showed significantly
less inter-subject variability than CVR maps to PETCO2 of
endogenous CO2.Discussion
The inter-subject variability of CVR to endogenous CO2 was
not reduced by individual correction of physiological motion effects using a
method like RETROICOR. Golestani et al (8) also showed
that such inter-subject variability in
CVR to endogenous CO2 persisted even after the application of the
respiratory response function (RRF) (8-10) for BOLD data. Therefore, neither motion effects of
respiration nor RRF have significant effect on inter-subject variability. Different from our work, Golestani et al (8) did not present CVR
from external CO2 challenge from the same subjects for comparison. Since RRF is expected to be equally applied to
O2 and CO2 to modulate their variations, our result of individual
CVR maps showing different inter-subject variability for O2 and CO2
was a further indication that RRF could not be used to modulate inter-subject
variability. The reduced inter-subject variability for individual CVR results
of endogenous O2 is consistent with the group averaged result (11) of O2 variation being superior to CO2
variation in correlation with cerebral BOLD signal variation.Conclusion
There is a significant inter-subject variability in maps of CVR to
endogenous CO2. The
consequence is that PETCO2 obtained from external CO2
challenge and endogenous PETCO2 cannot be expected to
generate the same kind of regional CVR maps. Acknowledgements
This research was carried out in whole at the Athinoula A. Martinos
Center for Biomedical Imaging at the Massachusetts General Hospital, using
resources provided by the Center for Functional Neuroimaging Technologies,
P41EB015896, a P41 Biotechnology Resource Grant supported by the National
Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes
of Health, as well as the Shared Instrumentation Grant S10RR023043. This study was also
supported, in part, by National Center for Complementary and Integrative Health
(NCCIH) grant (R21AT010955). References
1. Mikulis DJ, Krolczyk G, Desal H, Logan
W, Deveber G, Dirks P, Tymianski M, Crawley A, Vesely A, Kassner A, Preiss D,
Somogyi R, Fisher JA. Preoperative and postoperative mapping of cerebrovascular
reactivity in moyamoya disease by using blood oxygen level-dependent magnetic
resonance imaging. J Neurosurg 2005;103(2):347-355.
2. Golestani AM, Wei LL, Chen JJ.
Quantitative mapping of cerebrovascular reactivity using resting-state BOLD
fMRI: Validation in healthy adults. NeuroImage 2016;138:147-163.
3. Liu P, Li Y, Pinho M, Park DC, Welch
BG, Lu H. Cerebrovascular reactivity mapping without gas challenges. NeuroImage
2017;146:320-326.
4. Cox RW. AFNI: software for analysis and
visualization of functional magnetic resonance neuroimages. Comput Biomed Res
1996;29(3):162-173.
5. Talairach J, Tournoux P. Co-planar
stereotaxic atlas of the human brain : 3-dimensional proportional system : an
approach to cerebral imaging. Stuttgart ; New York: Georg Thieme; 1988.
6. Gold S, Christian B, Arndt S, Zeien G,
Cizadlo T, Johnson DL, Flaum M, Andreasen NC. Functional MRI statistical
software packages: a comparative analysis. Hum Brain Mapp 1998;6(2):73-84.
7. Glover GH, Li TQ, Ress D. Image-based
method for retrospective correction of physiological motion effects in fMRI:
RETROICOR. Magn Reson Med 2000;44(1):162-167.
8. Golestani AM, Chang C, Kwinta JB,
Khatamian YB, Jean Chen J. Mapping the end-tidal CO2 response function in the
resting-state BOLD fMRI signal: spatial specificity, test-retest reliability
and effect of fMRI sampling rate. NeuroImage 2015;104:266-277.
9. Birn RM, Smith MA, Jones TB, Bandettini
PA. The respiration response function: the temporal dynamics of fMRI signal
fluctuations related to changes in respiration. NeuroImage 2008;40(2):644-654.
10. Chang C, Glover GH. Relationship between
respiration, end-tidal CO2, and BOLD signals in resting-state fMRI. NeuroImage
2009;47(4):1381-1393.
11. Chan ST, Evans KC, Song TY, Selb J, van
der Kouwe A, Rosen BR, Zheng YP, Ahn AC, Kwong KK. Dynamic brain-body coupling
of breath-by-breath O2-CO2 exchange ratio with resting state cerebral hemodynamic
fluctuations. PLoS One 2020;15(9):e0238946.